Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-15

Clinical Trial Update: Drug-drug Interaction Study(CKD-501, Amlodipine) [Phase 1]

View source ↗

Summary

Phase 1 drug-drug interaction study of CKD-501 with amlodipine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • CKD-501

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED